Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

In less than a month, this corporate giant had lost more than half its value. “This is a stock that every growth-oriented ...

In a statement, CVS Chief Executive David Joyner highlighted "a significant and durable recovery" at Aetna, and "strong retention" at CVS Caremark. Last quarter, CVS said that Aetna is exiting the ...

UnitedHealth is a beaten-down healthcare giant that trades at a lower valuation right now. Is UNH stock a good buy today?

Bank of America recently reduced its price target for UnitedHealth Group (UNH) from $350.00 to $300.00, maintaining a ...

UnitedHealth Group is also moving forward with cost-cutting initiatives to boost its bottom line. CEO Stephen Hemsley ...

Shares of UnitedHealth Group opened at their lowest point since early 2020 as the health insurance giant's second-quarter ...

UnitedHealth Group Incorporated (NYSE:UNH) is one of the most undervalued blue chip stocks to buy according to hedge funds. J ...

The health insurance giant’s second-quarter profit missed expectations as it continues to face higher medical costs.

UnitedHealth Group Incorporated stock is oversold, trading at 12x 2026 profits with a 3.3% dividend yield. Click for more on ...

According to the UnitedHealth Group, it will value its share price at approximately $16 per share, which might generate revenue between $445.5 billion and $448 billion. However, Wall Street had higher ...

Humana's stock has lost 3.9% in 2025, while UnitedHealth shares have shed 48.4% and Centene's stock has dropped 57.1%. In comparison, the Health Care Select Sector SPDR ETF XLV has slipped 2.2% this ...